Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0882420150890020259
Korean Journal of Medicine
2015 Volume.89 No. 2 p.259 ~ p.263
TNF-¥á Inhibitor Treatment in an Ankylosing Spondylitis Patient with Secondary Amyloidosis that Manifest with Diarrhea: A Case Report
Lee Jae-Hyun

Moon Jin-Young
Lee Hyun-Woo
Chang Sung-Hae
Lee Eun-Bong
Song Yeong-Wook
Lee Eun-Young
Abstract
Secondary amyloidosis (Amyloid A amyloidosis) occurs when serum amyloid S accumulates in various tissues and organs. It often accompanies chronic inflammatory disease, especially rheumatoid arthritis, as well as ankylosing spondylitis (AS) and Crohn¡¯s disease. Although amyloid deposits were reported in 7% of the abdominal fatty tissue samples from AS patients, most of the patients had no symptoms. In a large study, 1.1% of 730 patients with AS were diagnosed with amyloidosis. Most of them showed renal involvement, while none had gastrointestinal symptoms. In South Korea, only a few cases of gastrointestinal involvement of secondary amyloidosis have been reported in AS patients, and there is no report on the effect of a tumor necrosis factor (TNF)-¥á inhibitor. We report a case of secondary amyloidosis in an AS patient who improved with the TNF-¥á inhibitor etanercept.
KEYWORD
Amyloidosis, Spondylitis, Ankylosing, TNFR-Fc fusion protein
FullTexts / Linksout information
 
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø